Magrolimab

Item number	Size	Delivery time	Price
TGM-T35390-1mg	1 mg	7 - 10 business days*	189.00€
TGM-T35390-5mg	5 mg	7 - 10 business days*	589.00€
TGM-T35390-10mg	10 mg	7 - 10 business days*	862.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that... more

Close menu

Product information "Magrolimab"

Description: Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma. Target: Others. References: Saygin C, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul,48:100791.

Keywords:	Magrolimab (anti-CD47), Hu5F9-G4
Supplier:	TargetMol
Supplier-Nr:	T35390

Properties

Conjugate:

Database Information

KEGG ID :	K06266 \| Matching products
UniProt ID :	Q08722 \| Matching products
Gene ID :	GeneID 961 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Magrolimab"

Write a review